Table 3.
Disease Responses and Outcomes Among Patients Diagnosed With Unfavorable Cytogenetics
| Abnormality | Patients Who Remained Alive
|
Patients Who Died
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CR (No.) | PR (No.) | PD/Relapse (No.) | Median Interval (years)
|
CR/PR (No.) | NA (No.) | PD/Relapse (No.) | Median Interval (years)
|
|||
| From Diagnosis | From HCT | From Diagnosis | From HCT | |||||||
| del 17p (n = 7) | 4 | — | — | 6.2 | 3.3 | 1 | — | 2 | 3 | 0.3 |
| del 11q (n = 7) | 1 | 2 | 2 | 8.2 | 2.1 | 1 | — | 1 | 7.5 | 0.7 |
| tri 12 (n = 7) | 4 | — | — | 6.7 | 4.4 | — | 2 | 1 | 3.8 | 0.2 |
| Complex (n = 9) | 4 | — | — | 11.4 | 5.7 | 1 | — | 4 | 10.5 | 3.5 |
Abbreviations: CR, complete remission; PR, partial remission; PD, progressive disease; NA, not assessed; HCT, hematopoietic cell transplantation.